| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 872.30M | — |
| Operating expense | — | — |
| Net income | 154.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, WST returned +42.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | +28.6% |
| 1 year | +42.9% |
| 5 years | -20.8% |
| 10 years | +347.5% |
| All-time high | $469.01 (Dec 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in WST would be worth today ›Yes. West Pharmaceutical Services, Inc. paid 4 dividends over the past 12 months. The most recent was $0.22 per share on Jul 29, 2026. The dividend yield is 0.25%.
West Pharmaceutical Services, Inc. stock trades on NYSE under the ticker symbol WST.
West Pharmaceutical Services, Inc. is part of the Healthcare sector.
West Pharmaceutical Services, Inc. has a market cap of 24.85B USD, based on the latest quote.
West Pharmaceutical Services, Inc. is expected to report earnings around Oct 22, 2026. That date is an estimate and has not been confirmed by the company.
West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging products. This segment also provides drug containment solutions in the form of vials, syringes, and cartridges; and self-injection devices; and a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. This segment primarily serves pharmaceutical, diagnostic, and medical device companies. It sells and distributes its products through its sales force and distribution network, contract sales agents, and regional distributors. West Pharmaceutical Services, Inc. was founded in 1923 and is headquartered in Exton, Pennsylvania.
